Summit Street Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-30,097
| Closed | -$875K | – | 32 |
|
|
2018
Q4 | $875K | Hold |
30,097
| – | – | 0.99% | 31 |
|
|
2018
Q3 | $1.38M | Hold |
30,097
| – | – | 1.35% | 27 |
|
|
2018
Q2 | $1.13M | Hold |
30,097
| – | – | 1.09% | 30 |
|
|
2018
Q1 | $889K | Sell |
30,097
-114,000
| -79% | -$3.37M | 0.88% | 31 |
|
|
2017
Q4 | $4.95M | Buy |
144,097
+6,986
| +5% | +$240K | 4.88% | 2 |
|
|
2017
Q3 | $4.96M | Sell |
137,111
-20,000
| -13% | -$724K | 5.67% | 2 |
|
|
2017
Q2 | $4.06M | Hold |
157,111
| – | – | 4.67% | 2 |
|
|
2017
Q1 | $3.02M | Buy |
157,111
+21,200
| +16% | +$407K | 3.31% | 12 |
|
|
2016
Q4 | $2.27M | Buy |
135,911
+40,400
| +42% | +$674K | 2.51% | 19 |
|
|
2016
Q3 | $1.97M | Buy |
+95,511
| New | +$1.97M | 2.11% | 30 |
|
|
2015
Q3 | – | Sell |
-77,810
| Closed | -$2.65M | – | 37 |
|
|
2015
Q2 | $2.65M | Hold |
77,810
| – | – | 2.54% | 19 |
|
|
2015
Q1 | $2.75M | Hold |
77,810
| – | – | 2.46% | 22 |
|
|
2014
Q4 | $2.65M | Buy |
+77,810
| New | +$2.65M | 2.6% | 19 |
|